Caxton Associates LP Neoleukin Therapeutics, Inc. Transaction History

Caxton Associates LP

  • $2.65 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.72 - $5.23 $27,808 - $84,558
-16,168 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$4.65 - $7.75 $75,181 - $125,302
16,168 New
16,168 $78,000
Q3 2020

Nov 16, 2020
SELL
$9.68 - $17.01 $205,148 - $360,492
-21,193 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$9.95 - $17.05 $210,870 - $361,340
21,193 New
21,193 $352,000

Others Institutions Holding NLTX

# of Institutions
1
Shares Held
199K
Call Options Held
0
Put Options Held
0
View Full List

About Neoleukin Therapeutics, Inc.

NLTX Quotes by TradingView
  • Ticker NLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,579,900
  • Description
  • Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...
More about NLTX
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email